Chemical Structure (Sumatriptan 01)
Sumatriptan Succinate And Naproxen Sodium Tablet
Product Images NDC 44183-850
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Sumatriptan Succinate And Naproxen Sodium (NDC 44183-850). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Currax Pharmaceuticals Llc Dba Cypress, Hawthorn, Macoven, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Chemical Structure (Sumatriptan 02)
Figure 1 (Sumatriptan 03)
This is a table representing the percentage of patients who experienced relief from headaches. The table includes data for Sumatriptan and Naproxen Sodium Tablets 85/500 mg, Sumatriptan 85 mg, Naproxen Sodium 500 mg, and a placebo.*
Figure 2 (Sumatriptan 04)
This text represents a graph or chart showing the percentage of patients who took rescue medication after taking Sumatriptan and Naproxen Sodium Tablets with a strength of 85/500 mg at different time intervals after taking the medication (10, 12, and 14 hours post-dose). Therefore, it does not include enough information to generate a useful description.*
Principal Display Panel (85 mg/500 mg Tablet Bottle Label)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
